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Abstract
Background: The differences between the metastatic property of moderately (Mod) and well (Wel) differentiated
colorectal adenocarcinoma remain unclear. Since Mod is unable to form complete acini, therefore an epithelial-
mesenchymal transition (EMT) can occur in that structure. Herein, we hypothesized that Mod metastasizes more
easily than the Wel counterparts.
Methods: The medical records of 283 consecutive patients with Mod (n = 71) or Wel (n = 212) who underwent
surgery were reviewed between January 1, 2001, and December 31, 2003, for actual 5-year overall survival. We
examined the differences between the clinicopathological characteristics of the Mod and the Wel groups.
Results: The lymph node involvement (p < 0.0001), lymphatic permeation, venous permeation, depth of invasion,
liver metastasis, and carcinomatous peritonitis were significantly higher in the Mod group in comparison to the
Wel group. The independent risk factors by a logistic regression analysis for lymph node involvement were as
follows: lymphatic permeation, liver metastasis, and Mod (p = 0.0291, Relative Risk of 1.991: 95% Confidence
Interval: 1.073-3.697). A Kaplan-Meier survival curve showed that Mod had a trend towards a poor survival
(p = 0.0517).
Conclusion: Mod metastasizes to the lymph nodes more easily in comparison to Wel. Therefore, patients with
Mod may be considered the existence of lymph node involvement.
Background
The classification of colorectal cancer such as the TNM
classification and Duke’s classification do not include
the type of histology. Both poorly differentiated adeno-
carcinoma (Por) [1,2] and mucinous carcinoma (Muc)
[3] have a worse prognosis with higher rates of metasta-
sis. However, the histological type of most colorectal
cancers are Wel or Mod, and Por and Muc occur in
only a small population [4-6]. Since most clinicians
believe that Mod is recognized equally well as Wel,
therefore there have been no reports comparing the
characteristics of Mod in comparison to Wel. In this
study, we evaluated whether Mod has a higher rate of
metastasis in comparison to Wel, and verified that the
histological difference is indicative of the metastatic sta-
tus and the phenotype of colorectal cancer.
Methods
Two hundred and eighty three patients, 170 males and
113 females of 26 to 91 years of age were included in
this study between January 1, 2001, and December 31,
2003, for actual 5-year overall survival. All of them
underwent appropriate colorectal surgery with lymph
node resection, and received appropriate chemotherapy
for metastatic colorectal cancer. All of the surgical spe-
cimens were subjected to a histological analysis by
experienced pathologists. The patients were divided into
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Muc, and Por. In classifying the carcinoma, based on
the least differentiated component, not including the
leading front of invasion, the predominant pattern of
the tumor was selected to represent its histological type
and grade. In order to compare the differences between
Mod and Wel in this study, the patients with Muc and
Por were excluded. The Mod group included 71
patients, and the Wel group included 212 patients. The
lymph node involvement (positive or negative), the
depth of invasion (T1T2 or T3T4), liver metastasis
(positive or negative), lung metastasis (positive or nega-
tive), carcinomatous peritonitis (positive or negative),
lymphatic permeation (positive or negative), venous per-
meation (positive or negative), gender (female or male),
and age (<60 or 60<) were evaluated to assess any differ-
ences between the Mod and Wel groups. A univariate
and multivariate analysis of data were carried out by
using the StatView 5.0 statistical analysis software. The
Chi-square test was used to detect differences between
the groups. A logistic regression analysis was conducted
for the multivariate analysis. All tests were considered
significant at p < 0.05. We evaluated the overall survival
by the Kaplan-Meier method. The study received the
approval from Wakayama Medical University Ethics
Committee, and was in compliance with the Helsinki
Declaration.
Results
A univariate analysis of the histological type showed that
the lymph node involvement (p < 0.0001), lymphatic per-
meation (p = 0.0001), venous permeation (p = 0.0003),
depth of invasion (p = 0.0018), liver metastasis (p =
0.0096), and peritonitis carcinomatosa (p = 0.0143) were
significantly higher in the Mod group (Table 1) in compar-
ison to the Wel group. Thereafter, we performed a logistic
regression analysis of the factors that were found to be sig-
nificant by the univariate analysis. A multivariate analysis
of the lymph node involvement indicated that the inde-
pendent predictive factors were lymphatic permeation
(p = 0.0127, Relative Risk 2.650: 95% Confidence Interval
1.232-5.704), liver metastasis (p = 0.0240, 2.804: 1.145-
6.867), and the histological type of tumor (Mod) (p =
0.0291, 1.991: 1.073-3.697) (Table 2). A multivariate analy-
sis of lymphatic permeation showed that the independent
predictive factors were venous permeation (p < 0.0001,
4.713: 2.393-9.281), depth of invasion (p = 0.0006, 3.571:
1.325-6.161), lymph node involvement (p = 0.0074, 2.857:
1.073-3.697), and the histological type of tumor (p =
0.0390, 2.828: 1.054-7.590) (Table 3). A multivariate analy-
sis of venous permeation, depth of invasion, liver metasta-
sis, and peritonitis carcinomatosa showed that there were
no associations between any of these factors and the histo-
logical type. A univariate and multivariate analysis showed
that Mod was an independent factor for lymph node
involvement and lymphatic permeation. The Kaplan-
Meier survival curve showed that patients with the Mod
histology had a shorter survival (p = 0.0517) (Figure 1).
Discussion
Most surgeons believe that the characteristics of Mod
are similar to Wel, therefore patients with the Mod his-
tology have been treated similarly to patients with the
Wel histology. Our data indicated that Mod is more
likely to metastasize to the lymph node in comparison
to Wel. A multivariate analysis of lymph node metasta-
sis showed that the histological type is ranked third
after lymphatic permeation and liver metastasis. The
depth of invasion was not an independent marker for
lymph node metastasis. This suggested that the histolo-
gical type including Mod is more important than the
depth of invasion. Whereas, a multivariable analysis for
Table 1 Comparison between Mod*
1 and Wel*
2 by a
univariate analysis
Mod (n = 71) Well (n = 212) P value
Lymph node involvement 44(62.0%) 74(34.9%) <0.0001
Lymphatic permeation 65(91.5) 146(68.9) 0.0001
Venous permeation 59(83.1) 126(59.4) 0.0003
Depth of invasion (T3T4) 66(93.0) 161(75.9) 0.0018
Liver metastasis 15(21.1) 20(9.4) 0.0096
Carcinomatous peritonitis 7(9.9) 6(2.8) 0.0143
Age (60<) 52(73.2) 142(67.0) 0.3256
Gender (female) 29(40.8) 84(39.6) 0.8556
Lung metastasis 1(1.4) 3(1.4) 0.9967
*1 Mod: Moderately differentiated adenocarcinoma;
*2 Wel: Well differentiated adenocarcinoma
Table 2 A multivariate analysis of the lymph node
involvement
P value RR*
1(95% CI*
2)
Lymphatic permeation 0.0127 2.650 (1.232-5.704)
Liver metastasis 0.0240 2.804 (1.145-6.867)
Mod differentiated*
3 0.0291 1.991 (1.073-3.697)
*1 RR, Relative Risk; *2 95%CI, 95% Confidence Interval;
*3 Mod differentiated: Moderately differentiated adenocarcinoma
Table 3 A multivariate analysis of the lymphatic
Permeation
P value RR*
1(95% CI*
2)
Venous permeation <0.0001 4.713 (2.393-9.281)
Depth of invasion 0.0006 3.571 (1.325-6.161)
Lymph node involvement 0.0074 2.857 (1.073-3.697)
Mod differentiated*
3 0.0390 2.828 (1.054-7.590)
*1 RR, Relative Risk; *2 95%CI, 95% Confidence Interval
*3 Mod differentiated: Moderately differentiated adenocarcinoma
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fourth rank after venous permeation, depth of invasion,
and lymph node involvement. It indicated that histologi-
cal type is also important for metastasis to lymphatic
vessels. Our results mean that surgeons may consider
appropriate surgery with lymph node resection for Mod,
if they could have histological information by biopsy or
total biopsy such as endoscopic submucosal dissection.
The patients with Wel or Mod underwent surgery
with lymph node resection and received appropriate
chemotherapy for lymph node (Stage III) and hemato-
genous metastatic (Stage IV) colorectal cancer. Our
results showed that Mod is correlated with lymph node
metastasis, therefore the more number of patients with
Mod received chemotherapy than Wel. However, our
data indicated that the patients with Mod have a trend
towards a poorer prognosis in comparison to the
patients with Wel. It could be that Stage II colorectal
cancer with Mod has micrometastasis, or that Mod is
resistant to current chemotherapy. The treatment of
patients with Mod, especially for Stage II, by adjuvant
chemotherapy may be recommended.
What is the difference between Mod and Wel? Well
differentiated adenocarcinoma has a well-constructed
structure, namely well formed acini and tubes. However,
moderately differentiated adenocarcinoma are character-
ized by a collapsed structure such as the cribriform pat-
tern [7]. It is postulated that these morphological
changes are indicative of an epithelial-mesenchymal
transition, and therefore it might be thought that Mod
is derived from Wel by the induction of EMT [8]. In
addition, EMT was reported to play an essential role in
tumorigenesis [9], invasion [8] and metastasis [10]. If
Mod is derived from Wel, then Mod may be a meta-
static phenotype of Well. Further cellular and molecular
examinations are required to confirm this hypothesis.
To some extent, the differences between Mod and
Wel have been reported by others [2,6,11]. However, we
are the first one to report that Mod is more likely to
metastasize than Wel, and that the patients with Mod
have a trend towards a poorer prognosis than the
patients with Wel. This confirms that the characteristics
of Mod have been erroneously thought of as similar to
Wel. In this study, we have clearly shown that Mod has
a greater lymph node metastatic phenotype than Wel.
Further studies to characterize Mod are required in
order to understand the mechanism of metastasis and
the morphological changes of the cancer tissue.
Conclusion
The differences in the lymph node metastatic property
of Mod in comparison to Wel has been clearly demon-
strated in this study. The patients with stage II moder-
ately differentiated colorectal cancer may therefore be
treated carefully with a lymph node resection and adju-
vant chemotherapy. The mechanism of the morphologi-
cal changes between Mod and Wel is required for
further investigation.
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